15 Jan Health Data News Roundup: Elevance Medicare Advantage Star Ratings Lawsuit; ACA Enrollment Highest; and MA Studies

Welcome to the Health Data Weekly News Roundup from IMAT Solutions. As the power of data continues to grow in the healthcare arena, today’s care organizations need to be on the forefront of all news and trends to help ensure that their data analytics efforts deliver accountable and informed care. Each week, we will provide you with the actionable news you need to meet these goals.

Elevance Health Lawsuit Slams Medicare Advantage Star Ratings Calculation
Elevance Health has filed a lawsuit against the Department of Health and Human Services (HHS), alleging its methodology for determining Medicare Advantage star ratings is unlawful.

ACA Signups Surpass 20 Million for the 1st Time
Over 20 million people have enrolled in individual insurance plans on the ACA exchange for 2024. The enrollment total is the highest in the exchange’s history, surpassing last year’s enrollment of 16 million.

Six American Companies Ranked Among World’s Largest Insurers
UnitedHealth Group is the world’s largest insurance company by net premiums for the ninth year in a row, according to AM Best’s annual ranking. UnitedHealth Group grew its net premiums by 14 percent in 2022, reaching $257.2 billion.

Elevance Health Plans to Acquire TX-Based Infusion Therapy Provider
Elevance Health has entered into an agreement to acquire infusion therapy provider Paragon Healthcare, improving access to specialty medication for members, the payer announced.

Alignment Health Grows its Medicare Advantage Membership by 44 Percent
Alignment Health is beginning 2024 with 155,000 Medicare Advantage members, and the company grew its Medicare Advantage membership by 44 percent year over year.

What Five Recent Studies Found About Medicare Advantage
Recent research on Medicare Advantage has tracked competition in local markets and investigated the rates of biosimilar drug uptake in both MA and traditional Medicare. Here are five Medicare Advantage findings Becker’s has reported since mid-November.